Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Breast Neoplasms 3Wilms Tumor 2Prostatic Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Carcinoma, Intraductal, Noninfiltrating 2Adenocarcinoma, Bronchiolo-Alveolar 2Adenocarcinoma of Lung 2Salivary Gland Neoplasms 1Rectal Neoplasms 1Lung Neoplasms 1Head and Neck Neoplasms 1Germinoma 1Extensive Stage Small Cell Lung Carcinoma 1Ependymoma 1Diabetes Insipidus 1Carcinoma, Ductal, Breast 1Breast Carcinoma In Situ 1Anatomic Stage II Breast Cancer AJCC v8 1

Interventions

Specimen Handling 5Magnetic Resonance Spectroscopy 5Cisplatin 4trastuzumab deruxtecan 3Platinum 3Docetaxel 3Carboplatin 3Biopsy 3pembrolizumab 2entrectinib 2darolutamide 2Trastuzumab 2Radiotherapy, Intensity-Modulated 2Leuprolide 2Goserelin 2Ado-Trastuzumab Emtansine 21,2-diaminocyclohexaneplatinum II citrate 2zanidatamab 1trastuzumab biosimilar HLX02 1sacituzumab govitecan 1pyrotinib 1pertuzumab 1luprolide acetate gel depot 1larotrectinib 1enfortumab vedotin 1dehydroftorafur 1ceralasertib 1camrelizumab 1bicalutamide 1apatinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Salivary Gland Neoplasms × Radiotherapy, Conformal × 90 days × Clear all
NCT01220583 2026-05-27

Radiation Therapy With or Without Chemotherapy in Treating Patients With High-Risk Malignant Salivary Gland Tumors That Have Been Removed By Surgery

Radiation Therapy Oncology Group

Phase 2 Active not recruiting
252 enrolled
Head & Neck

Head and Neck Neoplasms, Salivary Gland Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡